{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:13:56Z","timestamp":1794035636887,"version":"4.8.0"},"reference-count":71,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,10,31]],"date-time":"2009-10-31T00:00:00Z","timestamp":1256947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:title>Abstract.<\/jats:title>\n                  <jats:p>Nanotechnology, nanomedicine and nanotoxicology are complementary disciplines aimed at the betterment of human life. However, concerns have been expressed about risks posed by engineered nanomaterials (ENMs), their potential to cause undesirable effects, contaminate the environment and adversely affect susceptible parts of the population. Information about toxicity and biokinetics of nano\u2010enabled products combined with the knowledge of unintentional human and environmental exposure or intentional delivery for medicinal purposes will be necessary to determine real or perceived risks of nanomaterials. Yet, results of toxicological studies using only extraordinarily high experimental doses have to be interpreted with caution. Key concepts of nanotoxicology are addressed, including significance of dose, dose rate, and biokinetics, which are exemplified by specific findings of ENM toxicity, and by discussing the importance of detailed physico\u2010chemical characterization of nanoparticles, specifically surface properties. Thorough evaluation of desirable versus adverse effects is required for safe applications of ENMs, and major challenges lie ahead to answer key questions of nanotoxicology. Foremost are assessment of human and environmental exposure, and biokinetics or pharmacokinetics, identification of potential hazards, and biopersistence in cells and subcellular structures to perform meaningful risk assessments. A specific example of multiwalled carbon nanotubes (MWCNT) illustrates the difficulty of extrapolating toxicological results. MWCNT were found to cause asbestos\u2010like effects of the mesothelium following intracavitary injection of high doses in rodents. The important question of whether inhaled MWCNT will translocate to sensitive mesothelial sites has not been answered yet. Even without being able to perform a quantitative risk assessment for ENMs, due to the lack of sufficient data on exposure, biokinetics and organ toxicity, until we know better it should be made mandatory to prevent exposure by appropriate precautionary measures\/regulations and practicing best industrial hygiene to avoid future horror scenarios from environmental or occupational exposures. Similarly, safety assessment for medical applications as key contribution of nanotoxicology to nanomedicine relies heavily on nano\u2010specific toxicological concepts and findings and on a multidisciplinary collaborative approach involving material scientists, physicians and toxicologists.<\/jats:p>","DOI":"10.1111\/j.1365-2796.2009.02187.x","type":"journal-article","created":{"date-parts":[[2009,10,31]],"date-time":"2009-10-31T08:15:06Z","timestamp":1256976906000},"page":"89-105","source":"Crossref","is-referenced-by-count":822,"title":["Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology"],"prefix":"10.1111","volume":"267","author":[{"given":"G.","family":"Oberd\u00f6rster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,12,11]]},"reference":[{"key":"e_1_2_9_2_2","unstructured":"[NIH] National Institutes of Health.National Institute of Health Roadmap for Medical Research: nanomedicine. 2006. Available at:http:\/\/nihroadmap.nih.gov\/nanomedicine\/. Accessed May 15 2006."},{"key":"e_1_2_9_3_2","volume-title":"Nanomedicine \u2013 An ESF \u2013 European Medical Research Councils (EMRC) Forward Look Report","author":"[ESF] European Science Foundation","year":"2004"},{"key":"e_1_2_9_4_2","doi-asserted-by":"crossref","unstructured":"Oberd\u00f6rsterG Oberd\u00f6rsterE Oberd\u00f6rsterJ.Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles.Env Health Perspect2005;113:823\u201339.","DOI":"10.1289\/ehp.7339"},{"key":"e_1_2_9_5_2","unstructured":"Society of Toxicology (SOT).2005. Available at:http:\/\/www.toxicology.org\/ai\/fa\/Definition_of_Toxicology.doc."},{"key":"e_1_2_9_6_2","unstructured":"Woodrow Wilson Intl. Center for Scholars.News release: nanotech\u2010enabled consumer products top the 1 000 mark. Release No. 64\u201009 August 25 2009. Available at: (http:\/\/www.nanotechproject.org)."},{"key":"e_1_2_9_7_2","unstructured":"NNI: Strategy for Nanotechnology\u2010related environmental health and safety research.2008. Available at:http:\/\/www.ostp.gov\/galleries\/NSTC\/NNI_EHS_Research_Strategy.pdf."},{"key":"e_1_2_9_8_2","unstructured":"Royal Society and Royal Academy of Engineering (UK)2004.Nanoscience and nanotechnologies: opportunities and uncertainties. Available at:http:\/\/www.royalsoc.ac.uk."},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1021\/nn9006835"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/17435390701314761"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-002-0647-3"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/089426802320282338"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/08958370050166796"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/08958370701479323"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfj140"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.9254"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.10216"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-8502(90)90265-Y"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/08958370902942517"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2008.09.014"},{"key":"e_1_2_9_21_2","article-title":"Nanoparticles damage brain cells","author":"Benninghoff AD","year":"2008","journal-title":"Environ Health News"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfj182"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00527.2002"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/08958370801915291"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.8006"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1094823"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.01-06-0308"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/17435390701882478"},{"key":"e_1_2_9_29_2","article-title":"Dose and response metrics in assessing in vitro and in vivo nanoparticle toxicity","volume":"108","author":"Han X","year":"2009","journal-title":"Toxicologist"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/0894268041457147"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/08958370490439650"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.9685"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/00984100290071649"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/09553007914551251"},{"key":"e_1_2_9_35_2","first-page":"209","volume-title":"Pulmonary Toxicology of Respirable Particles (19th Annual Hanford Life Sciences Symposium)","author":"Stradling GH","year":"1980"},{"key":"e_1_2_9_36_2","article-title":"Serum protein coated gold nanoparticles in the perfused human term placenta","volume":"108","author":"Rinderknecht A","year":"2009","journal-title":"Toxicologist"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1166\/jnn.2004.078"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608582104"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200700465"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608582104"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2005.02.002"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2008.09.050"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0805135105"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1080\/08958370490439597"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.9030"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1080\/01926230252929954"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1080\/10611860290031877"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfj130"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.2131\/jts.33.105"},{"key":"e_1_2_9_50_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2131\/jts.33.381","article-title":"Letter to the editor","volume":"33","author":"Ichihara G","year":"2008","journal-title":"J Toxicol Sci"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2008.111"},{"key":"e_1_2_9_52_2","first-page":"717","article-title":"Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats","volume":"69","author":"Davis JMG","year":"1988","journal-title":"Br J Exp Path"},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.2131\/jts.34.65"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.2486\/indhealth.45.379"},{"key":"e_1_2_9_55_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.12.6.7539275"},{"key":"e_1_2_9_56_2","doi-asserted-by":"publisher","DOI":"10.1006\/faat.1996.0040"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.10263"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfp100"},{"key":"e_1_2_9_59_2","first-page":"426","article-title":"Acute injury and regeneration of the mesothelium in response to asbestos fibers","volume":"128","author":"Moalli PA","year":"1987","journal-title":"Am J Pathol"},{"key":"e_1_2_9_60_2","first-page":"5153","article-title":"Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo","volume":"50","author":"Goodglick LA","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_9_61_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-069X-7-4"},{"key":"e_1_2_9_62_2","first-page":"501","article-title":"Experimental studies in rats on the effects of asbestos inhalation coupled with the inhalation of titanium dioxide or quartz","volume":"72","author":"Davis JMG","year":"1991","journal-title":"Int J Exp Pathol"},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.90287.2008"},{"key":"e_1_2_9_64_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-1468"},{"key":"e_1_2_9_65_2","volume-title":"Risk Assessment in the Federal Government: Managing the Process","author":"National Academy of Sciences (NAS)","year":"1983"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.3109\/08958379509015211"},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-8977-2-8"},{"key":"e_1_2_9_68_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/70.2.212"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfm018"},{"key":"e_1_2_9_70_2","article-title":"Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical\/biological response\u2010mixes","author":"Rushton EK","year":"2009","journal-title":"JTEH"},{"key":"e_1_2_9_71_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00178308"},{"key":"e_1_2_9_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-008-9446-4"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2009.02187.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.2009.02187.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T08:44:51Z","timestamp":1698914691000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2009.02187.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,11]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1365-2796.2009.02187.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2009.02187.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,11]]}}}